Common Name |
Cefepime
Description |
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime is usually reserved to treat severe nosocomial pneumonia, infections caused by mliti-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateChEBI
CefepimaChEBI
CefepimumChEBI
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidGenerator
Bristol-myers brand OF cefepime dihydrochlorideMeSH
Elan brand OF cefepime dihydrochlorideMeSH
CefepimMeSH
Cefepime hydrochlorideMeSH
AxépimMeSH
Bristol-myers squibb brand OF cefepime dihydrochlorideMeSH
MaxipimeMeSH
QuadrocefMeSH
Chemical Formlia |
C19H24N6O5S2
Average Molecliar Weight |
480.561
Monoisotopic Molecliar Weight |
480.124959288
IUPAC Name |
1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium
Traditional Name |
cefepime
CAS Registry Number |
88040-23-7
SMILES |
CON=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1
InChI Identifier |
InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1
InChI Key |
HVFLCNVBZFFHBT-ZKDACBOMSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of organic compounds known as 3-quaternary ammonium cephalosporins. These are cephalosporins that are substituted at the 3-position by a quaternary ammonium group.
Kingdom |
Organic compounds
Super Class |
Organoheterocyclic compounds
Class |
Lactams
Sub Class |
Beta lactams
Direct Parent |
3-quaternary ammonium cephalosporins
Alternative Parents |
N-acyl-alpha amino acids and derivatives
2,4-disubstituted thiazoles
1,3-thiazines
2-amino-1,3-thiazoles
N-alkylpyrrolidines
Heteroaromatic compounds
Tetraalkylammonium salts
Tertiary carboxylic acid amides
Carboxylic acid salts
Azetidines
Secondary carboxylic acid amides
Amino acids
Carboxylic acids
Monocarboxylic acids and derivatives
Dialkylthioethers
Thiohemiaminal derivatives
Azacyclic compounds
Carbonyl compounds
Hydrocarbon derivatives
Organic oxides
Organic salts
Organic zwitterions
Organopnictogen compounds
Primary amines
Substituents |
3'-quaternary ammonium cephalosporin
N-acyl-alpha amino acid or derivatives
Alpha-amino acid or derivatives
2,4-disubstituted 1,3-thiazole
Meta-thiazine
N-alkylpyrrolidine
1,3-thiazol-2-amine
Tertiary carboxylic acid amide
Thiazole
Quaternary ammonium salt
Pyrrolidine
Tetraalkylammonium salt
Azole
Heteroaromatic compound
Carboxylic acid salt
Carboxamide group
Amino acid
Amino acid or derivatives
Secondary carboxylic acid amide
Azetidine
Azacycle
Carboxylic acid derivative
Dialkylthioether
Carboxylic acid
Monocarboxylic acid or derivatives
Hemithioaminal
Thioether
Amine
Organopnictogen compound
Organic oxygen compound
Organic salt
Carbonyl group
Organic nitrogen compound
Organic oxide
Organic zwitterion
Organonitrogen compound
Organooxygen compound
Primary amine
Hydrocarbon derivative
Aromatic heteropolycyclic compound
Molecliar Framework |
Aromatic heteropolycyclic compounds
External Descriptors |
cephalosporin (CHEBI:478164 )
oxime O-ether (CHEBI:478164 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Anti-Bacterial Agents
Antibacterial Agents
Cephalosporins
Application |
Pharmaceutical
Cellliar locations |
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility1.73e-02 g/LNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.017 mg/mLALOGPS
logP-0.37ALOGPS
logP-4.3ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)3.25ChemAxon
pKa (Strongest Basic)4.06ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area150.04 Å2ChemAxon
Rotatable Bond Count7ChemAxon
Refractivity141.98 m3·mol-1ChemAxon
Polarizability47.53 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Not Available
Biological Properties |
Cellliar Locations |
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01413
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01413
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB01413
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
4586395
KEGG Compound ID |
C08111
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Cefepime
NuGOwiki Link |
HMDB15483
Metagene Link |
HMDB15483
METLIN ID |
Not Available
PubChem Compound |
5479537
PDB ID |
Not Available
ChEBI ID |
478164
Product: DUBs-IN-2
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
- Chapman TM, Perry CM: Cefepime: a review of its use in the management of hospitalized patients with pneumonia. Am J Respir Med. 2003;2(1):75-107. [PubMed:14720024 ]
|
Transporters
- General function:
- Involved in ion transmembrane transporter activity
- Specific function:
- Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3
- Gene Name:
- SLC22A5
- Uniprot ID:
- O76082
- Molecular weight:
- 62751.1
References
- Ganapathy ME, Huang W, Rajan DP, Carter AL, Sugawara M, Iseki K, Leibach FH, Ganapathy V: beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem. 2000 Jan 21;275(3):1699-707. [PubMed:10636865 ]
- General function:
- Involved in transporter activity
- Specific function:
- Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides. May constitute a major route for the absorption of protein digestion end-products
- Gene Name:
- SLC15A1
- Uniprot ID:
- P46059
- Molecular weight:
- 78805.3
References
- Ganapathy ME, Huang W, Rajan DP, Carter AL, Sugawara M, Iseki K, Leibach FH, Ganapathy V: beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem. 2000 Jan 21;275(3):1699-707. [PubMed:10636865 ]
- Luckner P, Brandsch M: Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1. Eur J Pharm Biopharm. 2005 Jan;59(1):17-24. [PubMed:15567297 ]
- General function:
- Involved in transporter activity
- Specific function:
- Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides
- Gene Name:
- SLC15A2
- Uniprot ID:
- Q16348
- Molecular weight:
- 81782.8
References
- Ganapathy ME, Huang W, Rajan DP, Carter AL, Sugawara M, Iseki K, Leibach FH, Ganapathy V: beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem. 2000 Jan 21;275(3):1699-707. [PubMed:10636865 ]
- Luckner P, Brandsch M: Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1. Eur J Pharm Biopharm. 2005 Jan;59(1):17-24. [PubMed:15567297 ]
PMID: 22267119